Skip to main content

Table 1 Summary of clinical features of reported RH cases

From: A case report of retiform hemangioendothelioma as pleural nodules with literature review

Author (N)

Age/Gender

Site

Immunochemistry

Metastasis

Treatment

Survival

Calonje (15)

9–78/9 F,6 M

6:lower limbs

ND

1/15

ND

ND

4:upper limbs

3:Trunk

1:Penis

1:Scalp

Fukunaga (1)

75/F

Lower limb

CD31, vimentin, UEA-1 (all), CD34, f-VIII (part)

0/1

ND

ND

Duke (1)

30/F

Upper limb, trunk

CD31, f-VIII

0/1

Excision

>10 years

Samz-Trelles (1)

11/M

Lower limb

Vimentin, f-VIII

0/1

Excision

>4 years

Schommer (1)

73/F

Trunk

CD31,UEA-1, f-VIII

0/1

Excision, RT, IT

>1 year

Darouti (1)

32/F

Lower limb

f-VIII

ND

ND

>1.5 years

Tan (1)

19/F

Lower limb

ND

0/1

Excision

>14 months

Ioannidon (1)

55/F

Upper limb

CD31

0/1

Excision

>4 years

Parson (1)

17–71/4 F,0 M

1:upper limb

CD31(4/4),

ND

ND

ND

1:trunk

D2-40(1/4),

1:head

VEGFR3(0/4)

1:lower limb

Bhutoria (1)

35/F

Trunk

ND

Lymph node

Excision

ND

Emberger (1)

17/M

Trunk

CD31,D2-40

0/1

Excision

>3 years

Zhang (1)

61/F

Head

CD34, f-VIII, vimentin

0/1

Excision(twice)

6 months

Aydıngöz (1)

60/F

Lower limb

ND

0/1

Excision

>2 years

Hirsh (1)

44/M

Trunk

CD31

0/1

Resection,chemoradiation

>36 months

Keiler (1)

11/F

Upper limb

ND

0/1

Excision

ND

O’Duffy (1)

18/M

Head

ND

Lymph node

Excision, RT

ND

Albertini(1)

6/F

Trunk

D2-40

Lung

Excision

6 months

Choi (1)

20/M

Upper limb

f-VIII

ND

Excision

ND

Couceiro (1)

50/F

Upper limb

ND

ND

Excision

>4 years

Mota (1)

26/F

Trunk

CD31, D2-40

ND

Excision

ND

Al-Faky

9/F

Head

CD31, CD34, D2-40, f-VIII

ND

Excision

>6 years

  1. ND not documented, M male, F female, UEA-1 ulex europaeus agglutinin 1, f-VIII factor VIII-related antigen, RT radiotherapy, IT immunotherapy